In terms of the timelines you spoke to earlier—Canada's timelines for a brand-new active ingredient, a brand-new chemical—we have a review period of about 18 months, which is our standard review time for a conventional chemical. That would compare with Australia's, which is 14 months, and with the United States', which is about 22 months. In the European Union, you're looking at about 18 to 24 months for a similar approval for a brand-new chemical.
In Canada, we deal with about 12 to 15 new chemicals each year. Fortunately, about one-third of those have recently been done jointly with the United States, and we're hoping to increase the number done jointly with other countries around the world.
We're meeting our expectation on those 18-month timelines in Canada about 85% to 90% of the time. In fact, with most of the joint reviews we're conducting with the U.S. EPA now and looking ahead to the future, we'll be done in less than 18 months, in part because of the efficiencies of sharing the workload.
Also, as almost an incentive to companies to come in for these joint or global reviews, we're trying to keep those timelines as tight as possible. The global review, which I spoke to earlier, will have an approximate 12-month to 13-month timeline.